Brian Johnson is an experienced professional in the field of pharmacology and toxicology, currently serving as the Director of Pharmacology & Toxicology at Intellia Therapeutics, Inc. since May 2023. Prior to this role, Brian held the position of Principal Scientist at Beam Therapeutics from June 2021 to May 2023 and worked as a Scientist at Boehringer Ingelheim from September 2006 to June 2021, with responsibilities as a Toxicology Study Director for GLP and non-GLP nonclinical drug safety studies. Earlier career experiences include serving as an Associate Research Scientist II at Bristol-Myers Squibb from 2004 to 2006 and as a Biochemist at Eli Lilly from 1996 to 2004. Brian holds a Bachelor of Science degree in Biology from the University of North Carolina at Chapel Hill.
This person is not in any teams
This person is not in any offices